As Europe charts its course for the next funding programme for research, Framework Programme 10 (FP10), the stakes have never been higher. In order to increase European competitiveness in research and innovation and generate better outcomes for patients, the Biomedical Alliance in Europe urges policymakers to embrace health and biomedical research as a strategic investment. We call for strong funding to support the translational health research value and innovation chain. We advocate for reducing the administrative burden in grant applications, and for simplification and harmonization of the regulatory framework. In addition, we call for strengthening of strategic leadership, coordination, collaboration and training. FP10 promises to transform European health research into a driver of societal well-being, economic growth and global leadership.
Keywords: Biomedical Alliance in Europe; European commission; Framework Programme 10; Horizon Europe; biomedical research; health research; translational research.
© 2025 Federation of European Biochemical Societies.